51³Ô¹Ïapp

About this webinar:
This webinar will investigate how staying in opioid agonist treatment (OAT) affects the patterns of substance use, overdose, and health service use among a group of men who were recently released from prison in Victoria, Australia. These men were regular injectors of drugs before they were imprisoned. The webinar will specifically cover the following points:

1. Incidence of non-fatal opioid overdoses and the resumption of drug injection after release from prison.
   
2. Impact of OAT on the frequency of drug injection, visits to emergency healthcare, and visits to primary healthcare.
3. Retention in OAT during the transition from prison to the community.

About this speaker:
Dr Michael Curtis is a post-doctoral research officer with the Disease Elimination program at the Burnet Institute and a research associate at the National Drug Research Institute, Curtin University. Michael’s research interests include the use of prospective surveys and linked administrative data to improve the health and well-being of marginalised groups, with a particular focus on people in prison and people who inject drugs. Michael completed a PhD in 2023 under the supervision of Professor Mark Stoové and Professor Paul Dietze at Monash University and Burnet Institute. Michael’s PhD examined the impact of retention in opioid agonist treatment on substance use, health and health service use among men recently released from prison. Michael previously worked as a social worker, primarily in homelessness and youth out-of-home care.